Stock Performance Review on Healthcare Sector -- Palatin Technologies, Centene, Anthem, and AMAG Pharma

Thursday, June 8, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 8, 2017 /PRNewswire/ --

On Wednesday, the New York headquartered

NASDAQ Composite ended the day at 6,297.38, up 0.36%; the Dow Jones Industrial Average edged 0.18% higher, to finish at 21,173.69; and the S&P 500 closed at 2,433.14, slightly gaining 0.16%. Gains were broad based as six out of nine sectors finished
the trading session in green. has initiated research reports on the following Healthcare stocks: Palatin Technologies Inc. (NYSE MKT: PTN), Centene Corp. (NYSE: CNC), Anthem Inc. (NYSE: ANTM), and AMAG Pharmaceuticals Inc. (NASDAQ: AMAG). Daily Stock Tracker published comprehensive and free research reports on these stocks today at:

Palatin Technologies 

Cranbury, New Jersey-based Palatin Technologies Inc.'s stock finished Wednesday's session 1.96% lower at $0.35 with a total trading volume of 732,361 shares. The Company's shares have advanced 2.97% in the previous three months. The stock is trading 7.79% below its 50-day moving average. Additionally, shares of Palatin Technologies, which develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the US, have a Relative Strength Index (RSI) of 42.24. PTN complete research report is just a click away and free at:


On Wednesday, shares in St. Louis, Missouri headquartered Centene Corp. recorded a trading volume of 1.43 million shares. The stock ended the session 1.82% higher at $77.62. The Company's shares have advanced 2.41% in the last one month, 10.51% in the previous three months, and 37.36% on an YTD basis. The stock is trading 5.48% above its 50-day moving average and 17.34% above its 200-day moving average. Moreover, shares of Centene, which operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the US, have an RSI of 63.29.

On June 07th, 2017, research firm Morgan Stanley initiated an 'Overweight' rating on the Company's stock. The complimentary report on CNC can be downloaded at:


Indianapolis, Indiana headquartered Anthem Inc.'s shares closed the day 0.36% higher at $188.33. The stock recorded a trading volume of 1.58 million shares, which was higher than its three months average volume of 1.45 million shares. The Company's shares have gained 4.73% in the last month, 13.69% over the previous three months, and 30.99% on an YTD basis. The stock is trading 7.73% and 25.55% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the US, have an RSI of 71.22.

On June 07th, 2017, research firm Morgan Stanley initiated an 'Equal-Weight' rating on the Company's stock. Sign up for your complimentary research report on ANTM at:

AMAG Pharma 

Shares in Waltham, Massachusetts headquartered AMAG Pharmaceuticals Inc. finished 2.99% lower at $16.25. The stock recorded a trading volume of 1.00 million shares. The Company's shares are trading below their 50-day moving average by 22.35%. Furthermore, shares of AMAG Pharma, which manufactures, develops, and commercializes therapeutics for women's health, anemia management, and cancer supportive care in the US, have an RSI of 32.10. Get free access to your research report on AMAG at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: (207) 331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store